Search

Your search keyword '"Benedicte A. Lie"' showing total 216 results

Search Constraints

Start Over You searched for: Author "Benedicte A. Lie" Remove constraint Author: "Benedicte A. Lie"
216 results on '"Benedicte A. Lie"'

Search Results

1. No replication of previously reported association with genetic variants in the T cell receptor alpha (TRA) locus for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)

2. The influence of HLA genotype on the development of metal hypersensitivity following joint replacement

3. Methotrexate Treatment of Newly Diagnosed RA Patients Is Associated With DNA Methylation Differences at Genes Relevant for Disease Pathogenesis and Pharmacological Action

4. Next-Generation Sequencing Identifies Extended HLA Class I and II Haplotypes Associated With Early-Onset and Late-Onset Myasthenia Gravis in Italian, Norwegian, and Swedish Populations

6. MicroRNA Expression Differences in Blood-Derived CD19+ B Cells of Methotrexate Treated Rheumatoid Arthritis Patients

7. Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study

8. Rheumatoid Arthritis Patients, Both Newly Diagnosed and Methotrexate Treated, Show More DNA Methylation Differences in CD4+ Memory Than in CD4+ Naïve T Cells

9. Accurate Adapter Information Is Crucial for Reproducibility and Reusability in Small RNA Seq Studies

10. Correction: Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy.

11. HLA‐DQ2 is associated with anti‐drug antibody formation to infliximab in patients with immune‐mediated inflammatory diseases

12. Supplementary figures legends from Identification of a Natural Killer Cell Receptor Allele That Prolongs Survival of Cytomegalovirus-Positive Glioblastoma Patients

13. Supplementary materials and methods from Identification of a Natural Killer Cell Receptor Allele That Prolongs Survival of Cytomegalovirus-Positive Glioblastoma Patients

14. Supplementary figures and tables from Identification of a Natural Killer Cell Receptor Allele That Prolongs Survival of Cytomegalovirus-Positive Glioblastoma Patients

15. Data from Identification of a Natural Killer Cell Receptor Allele That Prolongs Survival of Cytomegalovirus-Positive Glioblastoma Patients

16. Small extracellular vesicles have distinct CD81 and CD9 tetraspanin expression profiles in plasma from rheumatoid arthritis patients

17. Multimodal human thymic profiling reveals trajectories and cellular milieu for T agonist selection

18. Fine mapping of the major histocompatibility complex (MHC) in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) suggests involvement of both HLA class I and class II loci

19. <scp>HLA‐B</scp> *27 typing using a triplex real time <scp>PCR</scp> in routine laboratory

20. Increased muscle activity during sleep and more RBD symptoms in H1N1-(Pandemrix)-vaccinated narcolepsy type 1 patients compared with their nonnarcoleptic siblings

21. Correlation between gene expression and MRI STIR signals in patients with chronic low back pain and Modic changes indicates immune involvement

22. Identification of Novel Loci Shared by Juvenile Idiopathic Arthritis Subtypes Through Integrative Genetic Analysis

23. Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subset

24. T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytes

25. The influence of hla genotype on the development of metal hypersensitivity following joint replacement

26. No replication of previously reported association with genetic variants in the T cell receptor alpha (TRA) locus for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)

27. Genetic association study in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) identifies several potential risk loci

28. Systematic assessment of commercially available low-input miRNA library preparation kits

29. Maternal and Newborn Vitamin D–Binding Protein, Vitamin D Levels, Vitamin D Receptor Genotype, and Childhood Type 1 Diabetes

30. Allele imputation for the Killer cell Immunoglobulin-like Receptor KIR3DL1/S1

31. MicroRNA Expression Differences in Blood-Derived CD19+ B Cells of Methotrexate Treated Rheumatoid Arthritis Patients

32. Narcolepsy type 1 patients have lower levels of effector memory CD4

33. THE INFLUENCE OF HLA GENOTYPE ON SUSCEPTIBILITY TO, AND SEVERITY OF, COVID-19 INFECTION

34. Polymorphisms in the TP53-MDM2-MDM4-axis in patients with rheumatoid arthritis

35. Narcolepsy type 1 patients have lower levels of effector memory CD4+ T cells compared to their siblings when controlling for H1N1-(Pandemrix™)-vaccination and HLA DQB1∗06:02 status

36. High nocturnal sleep fragmentation is associated with low T lymphocyte P2Y11protein levels in narcolepsy type 1

37. The influence of HLA genotype on the severity of COVID-19 infection

39. Erik Thorsby (1938–2021)

40. The effect of infliximab in patients with chronic low back pain and Modic changes (the BackToBasic study): study protocol of a randomized, double blind, placebo-controlled, multicenter trial

41. Maternal Microchimerism in Cord Blood and Risk of Celiac Disease in Childhood

42. Transcriptome profiling of human thymic CD4+ and CD8+ T cells compared to primary peripheral T cells

43. An extension to: Systematic assessment of commercially available low-input miRNA library preparation kits

44. Human Leukocyte Antigen alleles associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

45. Allele imputation for the killer cell immunoglobulin-like receptor KIR3DL1/S1

46. Lack of Association among Peptidyl Arginine Deiminase Type 4 Autoantibodies,PADI4Polymorphisms, and Clinical Characteristics in Rheumatoid Arthritis

47. Fetal and Maternal Genetic Variants Influencing Neonatal Vitamin D Status

48. HLA haplotypes in primary sclerosing cholangitis patients of admixed and non-European ancestry

49. HLA class II alleles in Norwegian patients with coexisting type 1 diabetes and celiac disease

50. Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study

Catalog

Books, media, physical & digital resources